Receptors, CXCR4, antagonists & inhibitors

All categories
Name
Receptors, CXCR4, antagonists & inhibitors
Accession Number
DBCAT001712
Description

Not Available

Drugs
DrugDrug Description
MavorixaforA CXC chemokine receptor 4 antagonist used to treat WHIM syndrome.
MSX-122MSX-122 has been used in trials studying the treatment of Solid Tumors.
Drugs & Drug Targets
DrugTargetType
MavorixaforC-X-C chemokine receptor type 4target
MavorixaforCytochrome P450 3A4enzyme
MavorixaforCytochrome P450 2D6enzyme
MavorixaforCytochrome P450 3A5enzyme
MavorixaforCytochrome P450 2C19enzyme
MavorixaforCytochrome P450 2B6enzyme
MavorixaforCytochrome P450 1A2enzyme
MavorixaforCytochrome P450 2C8enzyme
MavorixaforCytochrome P450 2C9enzyme
MavorixaforP-glycoprotein 1transporter
MavorixaforSolute carrier family 22 member 2transporter
MavorixaforMultidrug and toxin extrusion protein 1transporter
MSX-122C-X-C chemokine receptor type 4target